Crewe Advisors LLC Nautilus Biotechnology, Inc. Transaction History
Crewe Advisors LLC
- $1.01 Billion
- Q3 2025
A detailed history of Crewe Advisors LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Crewe Advisors LLC holds 136,052 shares of NAUT stock, worth $247,614. This represents 0.01% of its overall portfolio holdings.
Number of Shares
136,052Holding current value
$247,614% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NAUT
# of Institutions
71Shares Held
61.7MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$29.7 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$22.9 Million0.02% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$13.1 Million0.26% of portfolio
-
Madrona Venture Group, LLC6.02MShares$11 Million36.76% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$6.97 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $227M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...